GLIPR1 and glioma: To avoid any potential anti-glioma effect of doxycycline and to furthermore limit positional effects of provirus compared to the use of cell clones, we decided to change our in vivo strategy and to employ our polyclonal, stable GliPR1 knockdown system (without requirement for doxycycline induction) for use in a survival study.